You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 10, October 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Behavioral Neurology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AMD OPINIONS
Pimozide at Least as Safe and Perhaps More Effective Than Olanzapine for Treatment of Morgellons Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Of the patients who present with cutaneous dysesthesia, those who believe that their discomfort is caused by invasion by some foreign agent are the most difficult to treat. Parasitic infestation may still be the most common delusion, but we now learn of a variety of other foreign elements subsumed under the rubric Morgellons disease and reported in detail on the Morgellons Web site (http://www.morgellons.org). For the patient, the false belief serves as a defense against the need to acknowledge psychological issues, so he or she may not readily accept psychotropic medication.1 Meehan et al2 describe sensitive and thoughtful interactions that enabled each of 3 patients to accept treatment with olanzapine, which resulted in a speedy resolution of their symptoms.

Meehan et al2 favor olanzapine over pimozide on the basis of a safer adverse effect profile and the fact that olanzapine requires no special monitoring. However, they fail to . . . [Full Text of this Article]


AUTHOR INFORMATION
Caroline S. Koblenzer, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Successful Treatment of Delusions of Parasitosis With Olanzapine
William J. Meehan, Sonia Badreshia, and Christine L. Mackley
Arch Dermatol. 2006;142(3):352-355.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.